Skip to main content

Get An Even Better Deal On CRMD Than Director Kaplan Did

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 17, CorMedix Inc's Director, Myron Kaplan, invested $90,477.00 into 15,000 shares of CRMD, for a cost per share of $6.03..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.